GW 6471 (GW6471; GW-6471) is a novel and potent PPARα antagonistwith an IC50 of 0.24 μ M.

Pirinixic Acid (also known as NSC 310038; NSC310038; WY-14643; WY 14643) is a novel, highly potent and selective peroxisome proliferator and activator of PPARα with important biological activity.

Elafibranor (formerly GFT505) is a dual agonist of the PPARα/δ (peroxisome proliferator-activated receptor-α and -δ) with EC50 values of 45 and 175 nM, respectively.

GW7647 (GW-7647) is a novel, selective and potent agonist of human and murine PPARα4 with EC50s of 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ and PPARδ, respectively.

PTGR2-IN-1 is a potent PTGR2 inhibitor.

Daidzein is a naturally occuring isoflavone phytoestrogen isolated from Leguminosae, used as a component of foods and dietary supplements.

Balaglitazone (also known as NNC-610645; NNC-612344; NN-2344; DRF-2593) is a selective partial agonist of PPARγ (peroxisome proliferator-activated receptor) with an EC50 of 1.351 μM for human PPARγ.

VCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ and CB2 receptor dual agonist with potent anti-inflammatory activity.

GW 590735 is a potent and selective PPARα agonist.

AMG-131, also known as (INT-131) is a novel and potent hypoglycemic agent.